REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Inverfarma Sas (Colombia)

Main Activities: In-Vitro Diagnostic Substance Manufacturing | Surgical Appliance and Supplies Manufacturing | Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Inverfarma Sas Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Inverfarma Sas is based in Colombia. The head office is in Cota. The enterprise currently operates in the In-Vitro Diagnostic Substance Manufacturing sector. The company was established on August 12, 1994. 52 (2024) employees currently work for Inverfarma Sas. There was a net sales revenue increase of 22.66% reported in Inverfarma Sas’s latest financial highlights for 2025. Its’ total assets recorded a growth of 8.32%. The net profit margin of Inverfarma Sas increased by 2.76% in 2025.

Headquarters
Zona Franca Intexzona Bd 23
Cota; Cundinamarca;

Contact Details: Purchase the Inverfarma Sas report to view the information.

Basic Information
Total Employees:
Purchase the Inverfarma Sas report to view the information.
Registered Capital:
Purchase the Inverfarma Sas report to view the information.
Financial Auditors:
Purchase the Inverfarma Sas report to view the information.
Incorporation Date:
August 12, 1994
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Inverfarma Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
22.66%▲
Total Operating Revenue
31.16%▲
Operating Profit
47.05%▲
EBITDA
40.7%▲
Net Profit/Loss for the Period
109.83%▲
Total Assets
8.32%▲
Total Equity
1.13%▲
Operating Profit Margin
1.78%▲
Net Profit Margin
2.76%▲
Return on Equity (ROE)
5.43%▲
Quick Ratio
-0.03%▼
Cash Ratio
-0.04%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo